Come join an international community to learn and help innovate in hypertrophic cardiomyopathy (HCM), the most common cause of sudden cardiac death in athletes and a growing cause of heart failure due to diastolic dysfunction, systolic dysfunction, obstruction, afib and other arrhythmias at all ages. Join clinicians, researchers, patients, and industry professionals as we tackle the many facets of diagnosis and management.                                              Covering cardiac echocardiography, MRI, stress testing, pharmacotherapy and new drugs, randomized trials, new and developing treatments, genetic testing and screening, patient education, alcohol septal ablation, surgical myectomy, heart transplantation, pacemakers, defibrillators and arrhythmia ablation.